Notices. Notice; establishment of a public docket; request for comments; correction
200 words·~1 min read·
/register/2018/03/09/2018-04774A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2018-N-0410] Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; establishment of a public docket; request for comments; correction. SUMMARY: The Food and Drug Administration is correcting a notice entitled “Peripheral and Central Nervous System Drugs Advisory Committee;
Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the **Federal Register** of February 22, 2018. The document was published with the incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115. SUPPLEMENTARY INFORMATION: In the **Federal Register** of Thursday, February 22, 2018 (83 FR 7727), in FR Doc. 2018-03603, on page 7727, the following correction is made: 1.
On page 7727, in the first column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0410.” Dated: March 5, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018-04774 Filed 3-8-18; 8:45 am]